Evaluation of the Prevalence and the Reversibility of the Lung Hyperinflation in Uncontrolled Persistent Asthmatic Patients With Dyspnea

Chiesi Farmaceutici S.p.A.1 个研究点分布在 1 个国家目标入组 450 人2011年2月

适应症Asthma

概览

阶段: 不适用
干预措施: 未指定
疾病 / 适应症: Asthma
发起方: Chiesi Farmaceutici S.p.A.
入组人数: 450
试验地点: 1
状态: 已完成
最后更新: 14年前

概览研究者入排标准结局指标研究点相似试验

概览

简要总结

The aim of this observational study is to evaluate the pulmonary hyperinflation and its immediate reversibility to a short acting beta2 agonist test in uncontrolled persistent asthmatic patients with dyspnea.

详细描述

The other objectives are : * the evaluation of the hyperinflation defined by an increase of the residual volume (RV), * the observation of the relationship between the hyperinflation and the asthma characteristics, * the study of the improvement of the functional parameters after a reversibility test * the evaluation of the correlation between hyperinflation parameters evolution, chest tightness and dyspnea

注册库

clinicaltrials.gov

开始日期

2011年2月

结束日期

2012年1月

最后更新

14年前

研究类型

Observational

性别

All

研究者

发起方

Chiesi Farmaceutici S.p.A.

责任方

Sponsor

入排标准

入选标准

•Patient with a diagnosis of uncontrolled persistent asthma (ACT \</= 19) or with an MRC score of dyspnea \>/= 1
•Patient requiring a check-up including a pulmonary function test by plethysmography with a reversibility test